Surpise, surprise. Sometimes we've given founders bad advice. The best ones pushed back.
Speedstrap is what they taught us. Out today: go.speedstrapping.com/book
Marcel Botha retweeted
Demis Hassabis says he can cure every disease in 10 years.
Most people roll their eyes when they hear this, but I don't.
Demis is the guy who just won the Nobel Prize for solving protein folding with AI (a problem biologists had been stuck on for 50 years).
But that was just one milestone in his much grander plan.
In 2010, he founded DeepMind with a 2-part mission: "solve intelligence, then use it to solve everything else."
Step 1: make AI good enough to do real science.
Step 2: point that AI at humanity's biggest problems.
Step one was AlphaFold.
He used AI to figure out the 3D shape of every protein in nature (which is basically what every drug attaches to).
Demis said it would have taken "a billion years of PhD time" to do by hand.
Step two is curing all disease.
And as of today, step two is fully funded.
Isomorphic Labs (his AI drug discovery company inside Google) just raised $2.1B led by Thrive Capital.
Here's where the money goes and what Demis thinks happens next:
> Drug discovery currently takes 5-10 years and costs billions per drug. That math is why most diseases don't have good treatments today.
> AI fixes the math. Their drug design engine compresses development from years to months. Maybe weeks.
> Isomorphic's first AI-designed cancer drug enters human trials this year.
> Their pipeline expands beyond the current 17 programs across cancer, immune diseases, and heart disease into more health domains.
> The endgame is personalized medicine: drugs designed overnight for your specific biology and your specific disease.
That last one is the whole point.
Today's drugs are mass-produced for an "average" patient who doesn't really exist.
So most existing treatments work inconsistently from person to person, and most rare diseases never get a treatment at all (no market = no drug).
When drug design gets fast and cheap, that whole calculus flips.
Cancer variants get drugs designed for that specific variant, rare diseases get treatments because economics stop mattering, and drug-resistant infections get new drugs faster than they can evolve.
That's what curing every disease actually looks like.
Now imagine what your life looks like in 2036.
A doctor draws your blood, sequences your genome, sends your disease profile to an AI.
By morning the AI has designed a custom drug for your specific biology.
Side effects, dosage, drug interactions all worked out before you take the first pill.
You and your kids never see a cancer ward.
That's what $2.1B is buying today.
Demis was right about AlphaFold.
If you consider the possibility that he's right again, every disease alive today is on borrowed time.
I’ve always believed the No.1 application of AI should be to improve human health.
That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease!
We are turbocharging that goal with $2.1B in new funding.
Marcel Botha retweeted
We're growing! For the good folks who've already left for the other platforms that shall not be named, please do forward/share. linkedin.com/feed/update/urn…
Marcel Botha retweeted
From Battleships to Ventilators - how @Newlab has transformed an old @BklynNavyYard building into a haven for tech startups! @NY1 #Newlab #Brooklyn #Tech #entrepreneurs #NYC
Marcel Botha retweeted
Newlab is honored to be named @FastCompany's Innovation by Design Company of the Year. Two Newlab ventures, Spiro Devices, and Applied XL, are also named as finalists. Learn more: https://nitter.cf/t.co/ERnubuEUuz
#newlab #transformativetechnology #tech #InnovationbyDesign
Marcel Botha retweeted
On this week's episode of Design Lab, I asked @johnmaeda practical advice on how to more creative.
https://nitter.cf/t.co/95QIDHjDnp
Marcel Botha retweeted
Looking forward to this!
This Post is from an account that no longer exists. Learn more
Marcel Botha retweeted
For anyone who feels like they “wasted” quarantine because they didn’t write a novel or learn a new language or get shredded, I have good news: Quarantine ain’t over get back inside.
Marcel Botha retweeted
We are still in a pandemic.
A behind the scenes look in an ER:
Marcel Botha retweeted
South African born, Canadian immigrant and American entrepreneur launches two US Astronauts into Space.
America is an idea.
Marcel Botha retweeted
Police departments and unions across America: are you taking a hard enough look at your ranks and weeding out officers prone to racism and brutality?
The integrity of your best officers is now increasingly at stake, because of your worst.
Marcel Botha retweeted
Public health communication through the graphic medium of the poster.
theatlantic.com/health/archi…
Marcel Botha retweeted
Really lovely to watch this.
Whether it’s 100, 1,000, or 5,000 patients, NYC hospitals have broken out into 🎵 when someone beats coronavirus and is discharged.
Here’s a look at some of those celebrations helping bring the ☀️ out in grim times.
Video editor: @DanKomarinetz
NY Hospitals Break Out Into Song When Discharging Coronavirus Patients
Marcel Botha retweeted
Great stuff @marcelbotha nytimes.com/2020/04/20/techn…
Marcel Botha retweeted
Proud of my friend and BIF2018 storyteller @marcelbotha and the team @10XBeta for their heroic design effort to bring a $3,300 ventilator to market in a month. Check out the story in today’s @nytimes. #COVID19 nytimes.com/2020/04/20/techn…
Marcel Botha retweeted
Congrats to this team who built an emergency ventilator in 1 month!
nytimes.com/2020/04/20/techn…
Marcel Botha retweeted
Have been looking forward to this for a long time... Redesigning Healthcare Delivery: Operating Rooms, Hospitals... and Stadiums?
See you Thursday! Preview of the work & program we're launching at the interface of healthcare, policy & architecture here: SurgeryRedesign.com/fellowsh…
Marcel Botha retweeted
Excited to share our latest 7 investees at @urbanxaccel @UrbanUsCo. Creating exciting new solutions in EV charging, food quality, vertical take off EVs, ML for construction, ML for flood prevention, new materials for air quality, & sustainability fintech. techcrunch.com/2019/12/04/th…





























